Kenneth J Smith1, Roberta B Ness, Mark S Roberts. 1. Section of Decision Sciences and Clinical Systems Modeling, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. smithkj2@upmc.edu
Abstract
OBJECTIVE: Nulliparous women are frequently hospitalized for treatment of pelvic inflammatory disease (PID). GOAL: The goal of this study was to determine the economic feasibility of hospitalizing adolescents and young women for PID. STUDY DESIGN: The authors conducted a Markov decision model, estimating the cost-effectiveness of hospitalization compared with outpatient therapy for mild to moderate PID for adolescents and young women, calculating costs per quality-adjusted life-year (QALY) gained under various assumptions about hospitalization effects on complications. RESULTS: If hospitalization decreases PID complications by 10%, 20%, or 30%, the cost/QALY gained is 145,000 dollars, 67,400 dollars, or 42,400 dollars, respectively, compared with outpatient therapy. Assumptions about hospitalization effects on the development of chronic pelvic pain heavily weight the analysis; costs/QALY gained by hospitalization increase considerably if chronic pain is unaffected. CONCLUSION: Hospitalization for PID treatment to possibly preserve fertility in nulliparous young women and adolescents is unlikely to be economically reasonable even if substantial improvements in PID complication rates are assumed.
OBJECTIVE: Nulliparous women are frequently hospitalized for treatment of pelvic inflammatory disease (PID). GOAL: The goal of this study was to determine the economic feasibility of hospitalizing adolescents and young women for PID. STUDY DESIGN: The authors conducted a Markov decision model, estimating the cost-effectiveness of hospitalization compared with outpatient therapy for mild to moderate PID for adolescents and young women, calculating costs per quality-adjusted life-year (QALY) gained under various assumptions about hospitalization effects on complications. RESULTS: If hospitalization decreases PID complications by 10%, 20%, or 30%, the cost/QALY gained is 145,000 dollars, 67,400 dollars, or 42,400 dollars, respectively, compared with outpatient therapy. Assumptions about hospitalization effects on the development of chronic pelvic pain heavily weight the analysis; costs/QALY gained by hospitalization increase considerably if chronic pain is unaffected. CONCLUSION: Hospitalization for PID treatment to possibly preserve fertility in nulliparous young women and adolescents is unlikely to be economically reasonable even if substantial improvements in PID complication rates are assumed.
Authors: Maria Trent; Jamie Perin; Julia Rowell; Maunank Shah; Jennifer Anders; Pamela Matson; Rebecca M Brotman; Jacques Ravel; Phyllis Sharps; Richard Rothman; Hasiya E Yusuf; Charlotte A Gaydos Journal: J Infect Dis Date: 2021-08-16 Impact factor: 7.759
Authors: Maria Trent; Shang-En Chung; Charlotte Gaydos; Kevin D Frick; Jennifer Anders; Steven Huettner; Richard Rothman; Arlene Butz Journal: Eur Med J Reprod Health Date: 2016-08
Authors: Maria Trent; Harold Lehmann; Arlene Butz; Carol Thompson; Qiang Qian; Kevin D Frick Journal: Med Ther Med Reprod Gynecol Endocrinol Date: 2013 Oct-Dec
Authors: Maria Trent; Jamie Perin; Charlotte A Gaydos; Jennifer Anders; Shang-En Chung; Lisa Tabacco Saeed; Julia Rowell; Steven Huettner; Richard Rothman; Arlene Butz Journal: JAMA Netw Open Date: 2019-08-02